Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash	$ 25,536	$ 19,639
Accounts receivable	67	61
Inventory	410	278
Prepaid expenses, deposits, and other current assets	3,561	4,520
Total current assets	29,574	24,498
Fixed assets, net	1,595	1,783
Operating lease right-of-use assets	3,886	4,267
Intangible assets, net	1,052	1,424
Other assets	1,147	1,147
Total assets	37,254	33,119
Current liabilities:
Accounts payable	1,485	1,786
Accrued expenses and other current liabilities	6,657	6,626
Operating lease liabilities, current portion	1,333	1,565
Senior Secured Convertible Notes - at fair value	45,540	44,200
Total current liabilities	55,015	54,177
Operating lease liabilities, less current portion	2,814	2,960
Total liabilities	57,829	57,137
Commitments and contingencies (Note 8)
Stockholders’ Equity:
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,331,336 at March 31, 2024 and 1,305,213 shares at December 31, 2023	3,071	2,993
Common stock, $0.001 par value. Authorized, 50,000,000 shares; 8,858,597 and 8,578,505 shares outstanding as of March 31, 2024 and December 31, 2023, respectively	9	9
Additional paid-in capital	237,863	237,600
Accumulated deficit	(309,723)	(294,433)
Total PAVmed Inc. Stockholders’ Equity (Deficit)	(68,780)	(53,831)
Noncontrolling interests	48,205	29,813
Total Stockholders’ Equity (Deficit)	(20,575)	(24,018)
Total Liabilities and Stockholders’ Equity (Deficit)	$ 37,254	$ 33,119